ArticleHearts (Basel, Switzerland)2024

PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology.

Matthew L Repp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.